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The surface protein internalin A (InlA) contributes to the invasion of human intestinal epithelial cells 
by Listeria monocytogenes. Screening of L. monocytogenes strains isolated from human clinical cases (n � 
46), foods (n � 118), and healthy animals (n � 58) in the United States revealed mutations in inlA leading 
to premature stop codons (PMSCs) in L. monocytogenes ribotypes DUP-1052A and DUP-16635A (PMSC 
mutation type 1), DUP-1025A and DUP-1031A (PMSC mutation type 2), and DUP-1046B and DUP-1062A 
(PMSC mutation type 3). While all DUP-1046B, DUP-1062A, DUP-16635A, and DUP-1031A isolates (n � 
76) contained inlA PMSCs, ribotypes DUP-1052A and DUP-1025A (n � 72) contained isolates with and 
without inlA PMSCs. Western immunoblotting showed that all three inlA PMSCs result in the production 
of truncated and secreted InlA. Searches of the Pathogen Tracker database, which contains subtype and 
source information for more than 5,000 L. monocytogenes isolates, revealed that the six ribotypes shown to 
contain isolates with inlA PMSCs were overall more commonly isolated from foods than from human 
listeriosis cases. L. monocytogenes strains carrying inlA PMSCs also showed signiﬁcantly (P � 0.0004) 
reduced invasion of Caco-2 cells compared to isolates with homologous 3� inlA sequences without PMSCs. 
Invasion assays with an isogenic PMSC mutant further supported the observation that inlA PMSCs lead 
to reduced invasion of Caco-2 cells. Our data show that speciﬁc L. monocytogenes subtypes which are 
common among U.S. food isolates but rare among human listeriosis isolates carry inlA mutations that are 
associated with, and possibly at least partially responsible for, an attenuated invasion phenotype. 
Listeria monocytogenes is a facultative intracellular food-borne 
pathogen that may cause encephalitis, meningitis, septicemia, or 
spontaneous late-term abortions in susceptible individuals (34). 
Although the incidence of listeriosis is low, listeriosis has a high 
case fatality rate (20 to 30%), which makes this disease a consid­
erable public health concern (19). While L. monocytogenes can 
be classiﬁed into 13 different serotypes, only a few speciﬁc 
serotypes (4b, 1/2a, and 1/2b) are responsible for the majority 
(approximately 90%) of human listeriosis cases (18). Molecu­
lar subtyping studies have shown that L. monocytogenes iso­
lates can be grouped into three genetic lineages (reviewed in 
reference 41). While different studies have suggested that 
L. monocytogenes genetic lineages and subtypes differ in their 
epidemiological associations with speciﬁc hosts and nonhost 
environments (6, 12, 18, 22, 26, 39), very limited information is 
available on underlying genetic mechanisms that may be re­
sponsible for virulence differences among L. monocytogenes 
subtypes. A better understanding of genetic differences and 
their relationship to virulence differences among L. monocyto­
genes strains is critical to allow the development of accurate 
science-based L. monocytogenes risk assessments. 
Internalin (InlA), which is encoded by inlA, is an 800-amino­
acid (aa) surface protein that facilitates the entry of L. mono­
cytogenes into epithelial cells that express speciﬁc forms of 
E-cadherin. InlA appears to contribute to the invasion of in­
testinal epithelial cells by L. monocytogenes, an important ﬁrst 
step in the pathogenesis of systemic listeriosis (17). While InlA 
may also contribute to crossing of the placental barrier by 
L. monocytogenes (16), a role for InlA in the pathogenesis of 
listerial abortions could not be conﬁrmed in animal experi­
ments using a guinea pig model (1). Interestingly, a series of 
studies on L. monocytogenes strains isolated in France identi­
ﬁed at least six distinct nonsense mutations in inlA upstream of 
the region encoding the InlA membrane anchor (11, 13, 29, 
31), resulting in the expression of a truncated form of InlA 
which is secreted rather than anchored to the bacterial cell wall 
(13). No studies have characterized the presence of L. mono­
cytogenes isolates with nonsense mutations in inlA from coun­
tries other than France. 
A previous study (24) by our group on the molecular phy­
logeny and evolution of 120 L. monocytogenes isolates obtained 
from human and animal clinical cases and foods in the United 
States revealed three unique mutations in inlA leading to pre­
mature stop codons (PMSCs), which appear to differ from 
those previously described for L. monocytogenes isolates from 
France. The current study was thus conducted to (i) identify 
additional mutations leading to PMSCs in inlA by using a 
larger collection of L. monocytogenes isolates collected in the 
United States, (ii) deﬁne the prevalence of L. monocytogenes 
isolates harboring inlA PMSC mutations among human, ani­
TABLE 1. Description of L. monocytogenes isolate sets used for this study
 
Isolate 
set no. Description Purpose and use of isolate set
a 
1 
2 
3 
4 
5 
6 
36 food isolates representing all 36 EcoRI ribotypes found among 
food isolates collected in the United States, as described by 
Gray et al. (6) 
58 isolates representing L. monocytogenes EcoRI ribotypes 
commonly detected in feces from healthy ruminants, selected 
from a previously described collection of 108 L. monocytogenes 
fecal isolates from healthy ruminants (25) 
62 ribotype DUP-1062A isolates, representing all available 
DUP-1062A isolates from human listeriosis infections (n � 12), 
and 50 DUP-1062A food isolates selected from the 151 
DUP-1062A food isolates described by Gray et al. (6) to 
represent a variety of different ready-to-eat foods 
54 ribotype DUP-1052A isolates, representing all 30 DUP-1052A 
isolates from human listeriosis infections that were not 
previously characterized and 24 food isolates selected from the 
58 DUP-1052A food isolates described by Gray et al. (6) to 
represent a variety of different ready-to-eat foods 
Eight ribotype DUP-1025A isolates, representing all four 
DUP-1025A isolates from human listeriosis infections that were 
not previously characterized and selected food isolates (n � 4) 
All DUP-16635A isolates from foods (n � 4) that were not 
previously characterized 
Isolates were screened by sequencing an �1,600-bp 3� fragment 
of inlA to identify premature stop codon mutations associated 
with food isolates 
Isolates were screened by sequencing an �1,600-bp 3� fragment 
of inlA to identify premature stop codon mutations associated 
with isolates from healthy cattle 
Isolates were screened by PCR-RFLP to identify the presence 
of premature stop codon mutation type 3; all DUP-1062A 
isolates characterized by serotyping (n � 11) were serotype 
1/2a 
Isolates were screened by sequencing an �800-bp 3� fragment 
of inlA to identify the presence of premature stop codon 
mutation type 1; all DUP-1052A isolates characterized by 
serotyping (n � 10) were serotype 1/2b 
Isolates were screened by sequencing an �800-bp 3� fragment 
of inlA to identify the presence of premature stop codon 
mutation type 2; all DUP-1025A isolates characterized by 
serotyping (n � 9) were serotype 1/2b 
Isolates were screened by sequencing an �800-bp 3� fragment 
of inlA to identify the presence of premature stop codon 
mutation type 1; all DUP-16635A isolates (n � 5) were 
serotype 1/2b 
a The number of isolates characterized by serotyping included 8 DUP-1052A, 2 DUP-1025A, 1 DUP-1031A, 3 DUP-1062A, and 2 DUP-1046B isolates serotyped 
by Nightingale et al. (24) as well as 24 isolates that were not previously reported. 
mal, and food-source populations in the United States, and 
(iii) determine the invasion phenotypes of L. monocytogenes 
strains with and without inlA PMSCs. 
MATERIALS AND METHODS 
Bacterial strains. Six L. monocytogenes isolate sets (Table 1) were assembled 
from our culture collection of �5,000 L. monocytogenes isolates to screen for the 
presence of inlA PMSCs among L. monocytogenes strains isolated from different 
source populations in the United States. All isolates included in these six sets are 
described in detail in Supplemental Table 1 (http://www.foodscience.cornell.edu 
/wiedmann/Nightingale%20Supplementary2.txt). inlA sequencing data for these 
isolates have not been reported previously. 
inlA sequencing. L. monocytogenes isolates representing molecular subtypes 
commonly isolated from foods and fecal samples from healthy ruminants (isolate 
sets 1 and 2; Table 1) were screened for the presence of PMSCs in inlA by ﬁrst 
sequencing the 3� end of inlA (approximately 800 bp) and subsequently sequenc­
ing an additional, approximately 800-bp fragment (5� of the initial 3� 800-bp 
region sequenced) if no PMSC mutations were detected in the initial 3� frag­
ment. To speciﬁcally screen for the presence of PMSC mutation types 1 and 2, 
which were previously mapped to the 3� end of inlA (24), DNA sequencing of the 
3� fragment of inlA (approximately 800 bp) was conducted. Primer sequences 
used for PCR ampliﬁcation and/or DNA sequencing as well as PCR conditions 
are detailed in Supplemental Tables 2 and 3 (http://www.foodscience.cornell.edu 
/wiedmann/Nightingale%20Supplementary2.txt). PCR was performed using Taq 
polymerase (Promega, Madison, WI) as described previously (24). PCR products 
were also puriﬁed, quantiﬁed, and sequenced using forward and reverse PCR 
primers as described previously (24). Nucleotide sequences were proofread and 
aligned with Seqman and MegAlign (Lasergene software suite; DNAStar, 
Madison, WI), respectively. 
PCR-RFLP. Partial inlA DNA sequence data for four DUP-1062A and all 
available DUP-1046B L. monocytogenes isolates from food samples previously 
uncovered the presence of a speciﬁc PMSC mutation (PMSC mutation type 3) in 
these isolates (24). A PCR-restriction fragment length polymorphism (PCR­
RFLP) assay was developed to screen for the presence of this inlA PMSC 
mutation in DUP-1062A isolates from human clinical cases and from foods 
(Table 1). An analysis of inlA sequences with and without inlA PMSC mutation 
type 3 identiﬁed RsaI as a restriction enzyme that differentiates sequences with 
and without this mutation. PCR primers (Supplemental Table 2) were designed 
to amplify a 180-bp fragment of inlA encompassing PMSC mutation type 3. RsaI 
recognizes a sequence found in inlA sequences without PMSC mutation type 3, 
so L. monocytogenes isolates with PMSC mutation type 3 were expected to show 
a single 180-bp fragment after PCR-RFLP, while isolates without this mutation 
were expected to yield two fragments (117 and 63 bp). PCR was performed as 
described in Supplemental Table 3. PCR products were digested with RsaI (New 
England Biolabs, Beverly, MA) for 1 h at  37°C and subsequently analyzed by 
3.0% agarose gel electrophoresis. Isolates conﬁrmed by DNA sequencing to 
carry or not carry PMSC mutation type 3 were used as positive controls. 
Caco-2 invasion assays. Caco-2 invasion assays were performed essentially as 
previously described (28). Brieﬂy, L. monocytogenes isolates were grown over­
night at 30°C without shaking. Conﬂuent Caco-2 monolayers were inoculated 
with 2 � 107 L. monocytogenes cells/well. Serial dilutions of the inoculum were 
plated on brain heart infusion (BHI) agar (Difco Laboratories, Detroit, MI) 
plates. Inoculated Caco-2 monolayers were incubated for 30 min at 37°C, fol­
lowed by three washes with phosphate-buffered saline and the addition of fresh 
medium without antibiotics. Medium containing 150 �g/ml gentamicin was 
added at 45 min postinoculation to kill extracellular bacteria. At 90 min post­
inoculation, Caco-2 monolayers were washed three times with phosphate-buff­
ered saline. Caco-2 cells were lysed by the addition of cold sterile distilled water 
and vigorous pipetting. Intracellular L. monocytogenes cells were enumerated by 
spread plating lysed Caco-2 cell suspensions on BHI agar plates. The invasion 
efﬁciency was reported as the percentage of the inoculum recovered by the 
enumeration of intracellular bacteria. A standard laboratory control strain 
(10403S) and uninoculated BHI broth were included as controls in each invasion 
assay. Three independent invasion assays were performed for each L. monocy­
togenes strain tested (Table 2). 
Generation of an isogenic inlA PMSC mutant. An isogenic mutant of labora­
tory strain 10403S (2) carrying inlA PMSC mutation type 3 (located at codon 700 
of the inlA open reading frame) was generated. Site-directed mutagenesis was 
performed using SOE-PCR (splicing by overlap extension PCR) (10), using 
primers (5� to 3�) Marq 147 (AACTGCAGCTGGGAATTTATTGACTGG), 
Marq 149 (GTAAATTGAGCCTACAGCGTAATG), Marq 148 (CATTAC 
GCTGTAGGCTCAATTTAC), and Marq 150 (GCGGTACCTTGCTTGATT 
GGCGTTGGC). First, two fragments were ampliﬁed by PCR from strain 
10403S, using primer pairs Marq 147/Marq 149 and Marq 148/Marq 150. Primers 
Marq 148 and 149 are complementary and introduce inlA PMSC mutation type 
TABLE 2. L. monocytogenes strains and isolates used for Western blot analysis and invasion assays 
Strain (previous name) Genotype or ribotype Source or reference 
10403S Wild type 2 
FSL K4-006 (EJL12, HEL-202) 10403S �inlA 1 
FSL K4-007 (HEL-137) 10403S �inlB 15 
FSL K4-009 10403S �inlAB 14 
FSL W3-084 (HEL-399) 10403S inlA with stop codon at aa 700 (PMSC mutation type 3) This paper 
FSL F2-245a DUP-1052A, full-length inlA This paper 
FSL F2-563a DUP-1052A, PMSC mutation type 1 This paper 
FSL F2-897b DUP-1025A, full-length inlA This paper 
FSL R2-074b DUP-1025A, PMSC mutation type 2 This paper 
FSL F2-539 (EGD-e)c Full length inlA 5 
FSL F2-515c DUP-1062A, PMSC mutation type 3 This paper 
a FSL F2-245 and FSL F2-563 have identical 3� inlA sequences, except for premature stop codon mutation type 1 in isolate FSL F2-563. 
b FSL F2-897 and FSL R2-074 have identical 3� inlA sequences, except for premature stop codon mutation type 2 in isolate FSL R2-074. 
c FSL F2-539 (EGD-e) and FSL F2-515 have identical 3� inlA sequences, except for premature stop codon mutation type 3 in isolate FSL F2-515. 
3 (TAG) at codon 700. The PCR products were puriﬁed and combined in a Cell wall and supernatant fractions were prepared as previously described (36). 
second PCR with primers Marq 147 and 150. The 1,098-bp product was digested Equivalent amounts of culture (in optical density [OD] units) were loaded per 
with PstI and KpnI and ligated into pKSV7. The mutated inlA allele was veriﬁed lane. Proteins were detected by Western immunoblotting using a mouse anti-
by sequencing and recombined into the chromosome of L. monocytogenes 10403S InlA antiserum provided by T. Potter (National Jewish Medical and Research 
by allelic exchange as previously described (3). Center, Denver, CO) (15, 36). 
Western blotting. Western immunoblot analysis of bacterial cell wall and Phylogenetic inference. A multiple sequence alignment of the 3� end of inlA 
supernatant fractions for the presence of InlA was performed on L. monocyto- (706 nucleotides) was created in MegAlign using the inlA sequences for all 
genes grown in LB supplemented with 50 mM morpholinepropanesulfonic acid L. monocytogenes isolates (n � 160) sequenced for this study and sequences 
(MOPS) adjusted to pH 7.3, 25 mM glucose-1-phosphate, and 0.2% activated containing PMSCs from our previous study (24). This alignment was used to 
charcoal. Chloramphenicol was added (10 �g/ml) 10 min prior to the harvest. generate a data ﬁle for phylogenetic analyses containing a single representative 
FIG. 1. Full-length InlA (A) and locations of premature stop codons in InlA previously identiﬁed by research groups in France (B, C, D, E, 
H, and I) and reported here (F, G, and J). Full-length InlA represents the sequence for L. monocytogenes strain EGD-e. N, N-terminal end; S, 
signal sequence; LRR, leucine-rich repeat; IR, intergenic repeat; MA, membrane anchor; C, C-terminal end. Numbers below the EGD-e InlA 
sequence represent aa positions. Numbers at the right end for panels B to F represent the aa positions of the respective premature stop codons. 
TABLE 3. Occurrence of premature inlA stop codons among six 
EcoRI ribotypes found to contain these mutations 
Incidence of premature inlA 
stop codon (no. of isolates Prevalence (%) 
with mutation [no. of isolates Mutation of premature inlARibotype screened]) among isolates type stop codon among 
obtained from: all isolates 
Humans Food Total 
DUP-1052Aa 1 7 (35) 13 (27) 20 (62) 32.3 
DUP-16635Ab 1 0 (0) 5 (5) 5 (5) 100.0 
DUP-1025Ac 2 0 (5) 2 (6) 2 (11) 18.2 
DUP-1031Ad 2 0 (0) 1 (1) 1 (1) 100.0 
DUP-1062Ae 3 12 (12) 55 (55) 67 (67) 100.0 
DUP-1046B f 3 0 (0) 3 (3) 3 (3) 100.0 
a Data represent 54 isolates from isolate set 4 (Table 1), one food isolate with 
ribotype DUP-1052A from isolate set 1, and ﬁve human and two food isolates 
from the work of Nightingale et al. (24). 
b Data represent four isolates from isolate set 6 (Table 1) and one food isolate 
with ribotype DUP-16635A from isolate set 1. 
c Data represent eight isolates from isolate set 5 (Table 1), one food isolate 
with ribotype DUP-1025A from isolate set 1, and one human and one food 
isolate from the work of Nightingale et al. (24). 
d Data represent one food isolate with ribotype DUP-1031A from isolate set 1 
(Table 1). 
e Data represent 62 isolates from isolate set 3 (Table 1), one food isolate with 
ribotype DUP-1062A from isolate set 1, and four food isolates from the work of 
Nightingale et al. (24). 
f Data represent one food isolate with ribotype DUP-1046B from isolate set 1 
and two food isolates from the work of Nightingale et al. (24). 
isolate for each inlA allele (n � 38), using DnaSP, version 3.99 (32). A maximum 
likelihood phylogenetic tree was inferred using DNA substitution parameters 
selected by MODELTEST (30) and PAUP* (37), as previously described (24). 
Serotyping. Serotyping of L. monocytogenes was performed using the glass 
agglutination method (7, 38) and commercial Listeria antiserum (Seiken Listeria 
antiserum; Denka Seiken, Tokyo, Japan). Results were interpreted according to 
the serotyping scheme of Seeliger and Hohne (35). 
Statistical analysis. Chi-square tests were performed to describe the preva­
lence of PMSCs in food and human clinical isolates and to describe the distri­
bution of ribotypes that carry inlA PMSCs among isolates from foods and human 
clinical listeriosis cases. Fisher’s exact test was used if expected values were below 
5 for one or more cells. A nonparametric equivalent to the t test (Wilcoxon rank 
sum test) was used to assess the difference in invasion efﬁciencies between the 
two groups of L. monocytogenes strains studied (i.e., strains with and without 
premature inlA stop codons). P values of �0.05 were considered statistically 
signiﬁcant. 
Nucleotide sequence accession numbers. A single sequence representing each 
unique inlA allele (n � 38) identiﬁed in this study was deposited in GenBank 
(accession no. DQ125375 to DQ125412). Accession no. DQ125408, DQ125406, 
and DQ125387 represent inlA sequences containing PMSC mutation types 1, 2, 
and 3, respectively. Sequences for all isolates characterized by partial inlA se­
quencing in this study (n � 160) are available through Pathogen Tracker (www 
.pathogentracker.net). 
RESULTS AND DISCUSSION 
While previous studies described inlA PMSCs among 
L. monocytogenes strains isolated in France from human fecal 
carriers and foods as well as, less commonly, from human 
clinical cases (11, 13, 29, 31), we were not aware of any data on 
the presence and distribution of inlA PMSCs in L. monocyto­
genes isolates from countries other than France. Our data 
reported here show that (i) multiple distinct inlA PMSC mu­
tations are found in different L. monocytogenes EcoRI ribo­
types, which overall are commonly isolated from foods and 
rarely cause human disease in the United States; (ii) isolates 
carrying inlA mutations resulting in PMSCs show attenuated 
invasiveness in human intestinal epithelial cells; and (iii) inlA 
PMSC mutations 3� of the highly conserved leucine-rich repeat 
(LRR) region of InlA are rare among fecal isolates from 
healthy ruminants. Together with previous studies (11, 13, 29, 
31), our results suggest that L. monocytogenes isolates with 
PMSCs in inlA are distributed worldwide and may represent a 
signiﬁcant virulence-attenuated subpopulation of L. monocy­
togenes commonly isolated from foods. While the occurrence 
of multiple distinct ecologically successful inlA PMSC muta­
tions suggests positive selection for the loss of cell wall-an­
chored InlA, the reservoir(s) of L. monocytogenes strains with 
secreted InlA and the selective advantages associated with 
these mutations remain to be established. 
Multiple distinct inlA PMSCs are found in different L. mono­
cytogenes EcoRI ribotypes that are commonly isolated from foods 
and rarely cause human disease in the United States. A previous 
study by our group (24) identiﬁed three unique inlA PMSC 
mutations in four L. monocytogenes ribotypes (ribotypes DUP­
1052A, DUP-1062A, DUP-1046B, and DUP-1031A). Ribo­
types DUP-1062A and DUP-1052A were not only previously 
shown to be the two most common L. monocytogenes ribotypes 
among more than 30,000 food samples collected in the United 
States (together representing 41.7% of 502 L. monocytogenes 
food isolates [6]) but were also found to be signiﬁcantly more 
common among food isolates than among human clinical iso­
lates (6). We thus hypothesized that inlA PMSCs might be 
associated with reduced human virulence among certain 
L. monocytogenes subtypes found in the United States. Since 
previous studies in France have also found multiple mutations 
leading to PMSCs in the 3� region of inlA (11, 13, 29, 31), we 
initially sequenced the 3� region of inlA (covering the region 
where PMSCs were previously identiﬁed [11, 13, 24, 29, 31]) in 
36 L. monocytogenes isolates (isolate set 1; Table 1) represent­
ing all 36 ribotypes found among 502 previously collected U.S. 
food isolates (6). This isolate set included ribotypes commonly 
linked to human listeriosis cases (e.g., DUP-1038B, DUP­
1042B, and DUP-1044A [6]). We identiﬁed two additional 
ribotypes, DUP-1025A and DUP-16635A, which carry inlA 
PMSCs. The inlA mutations identiﬁed here occurred in the 
FIG. 2. Western blot detection of InlA from broth-grown bacteria. 
Strains tested included (i) the laboratory control strain 10403S, which 
encodes full-length InlA (2,400 bp, 800 aa); (ii) an isogenic 10403S �inlA 
mutant (HEL-202, FSL K4-006); (iii) an isogenic mutant with PMSC 
mutation type 3 in a 10403S background (HEL-399, FSL W3-084); (iv) a 
wild-type isolate with PMSC mutation type 1 (FSL F2-563); and (v) a 
wild-type isolate with PMSC mutation type 2 (FSL R2-074). Proteins in 
the cell wall (C) and in the supernatant (S) fraction were detected by 
Western immunoblotting with a mouse anti-InlA antiserum. 
FIG. 3. Phylogenetic tree depicting evolutionary relatedness of inlA alleles sequenced. The tree was constructed using a 706-bp 3� fragment of 
inlA. Alleles representing premature stop codon mutation types 1, 2, and 3 are marked PMSC 1, 2, and 3, respectively. Genetic lineage I (as 
determined by EcoRI ribotyping) isolates are shown in red, lineage II isolates are shown in green, and lineage III isolates are shown in blue. inlA 
sequence data for lineage III isolates (n � 3), which have previously been shown to be distantly related to lineage I and II isolates (42), were used 
as an outgroup to root the inlA maximum likelihood tree. Bootstrap conﬁdence measures above 50.0% for nodes in the inlA phylogram are shown 
at the nodes they describe. The inlA sequences used to construct this tree are available from GenBank (accession no. DQ125375 to DQ125412). 
same locations previously identiﬁed by our group (24) (Fig. 1). 
inlA PMSCs among the isolates screened thus represent three 
distinct mutation types (PMSC mutation types 1 through 3), 
with each occurring in two ribotypes (Table 3). All three inlA 
PMSC mutations observed here appear to be distinct from 
those reported in previous studies that provided DNA se­
quence data allowing us to map the speciﬁc mutations leading 
to PMSCs (13, 29, 31) (Fig. 1). We could not establish whether 
the mutations observed here were also distinct from those 
leading to truncated InlA in food and human clinical isolates 
collected in France (11), since these isolates were only char­
acterized by Western blot analysis, which does not permit a 
deﬁnitive identiﬁcation of speciﬁc mutations leading to PMSCs. 
All three inlA PMSCs observed here were located within 100 
aa of each other and were positioned 3� of the conserved LRR 
region and 5� of the C-terminal LPXTG membrane-anchoring 
motif (Fig. 1). The occurrence of inlA PMSCs in this region 
was previously linked to the production of a truncated InlA 
protein that is secreted rather than anchored to the cell wall 
(11, 13). Western blot analysis conﬁrmed that the inlA PMSCs 
reported here also result in the production of a truncated and 
secreted InlA protein (Fig. 2). 
Phylogenetic analyses showed that the inlA PMSCs reported 
here represent three distinct evolutionary events (Fig. 3). The 
clustering of the inlA sequences containing mutations leading 
to PMSCs is also consistent with the lineage classiﬁcation of 
the isolates carrying these mutations (Fig. 3). Speciﬁcally, inlA 
alleles carrying PMSC mutation types 1 and 2 group with other 
lineage I inlA sequences, and the PMSC mutation type 3 allele 
groups with lineage II isolates (Fig. 3). The lineage classiﬁca­
tion was also consistent with serotype classiﬁcation (Table 3). 
Isolates with PMSC mutation types 1 and 2 were serotype 1/2b, 
which is typical for lineage I strains (23), while isolates with 
PMSC mutation type 3 were serotype 1/2a, which is typical for 
lineage II strains (23). In a previous study (24), sequencing the 
3� 800 bp of inlA failed to reveal any PMSC mutations among 
36 lineage I L. monocytogenes isolates representing serotype 
4b, a serotype associated with the majority of human listeriosis 
TABLE 4. Frequency of L. monocytogenes ribotypes associated with premature inlA stop codons among isolates in the
 
Pathogen Tracker database
 
No. (prevalence [%]) of isolates in Pathogen Tracker c obtained from: Mutation SerotypeEcoRI ribotype Lineagea type (no.)b Humansd Animalse Foodsf Otherg Total 
DUP-1052A 1 I 1/2b (10) 35 (3.5) 1 (0.08) 78 (5.0) 82 (6.8) 196 (3.9) 
DUP-16635A 1 I 1/2b (5) 0 0 5 (0.3) 1 (0.1) 6 (0.1) 
DUP-1025A 2 I 1/2b (9) 5 (0.5) 2 (0.15) 6 (0.4) 4 (0.3) 17 (0.3) 
DUP-1031A 2 I 1/2b (1) 0 0 1 (0.06) 0 1 (0.02) 
DUP-1062A 3 II 1/2a (11) 12 (1.2) 0 170 (10.9)* 37 (3.1) 219 (4.3) 
DUP-1046B 3 II 1/2a (3) 0 0 3 (0.2) 0 3 (0.06) 
Total 1,009 1,297 1,562 1,213 5,081 
a Lineages were assigned based on the EcoRI ribotypes, as described by Wiedmann et al. (42). 
b Numbers reﬂect eight DUP-1052A, two DUP-1025A, one DUP-1031A, three DUP-1062A, and two DUP-1046B isolates serotyped by Nightingale et al. (24) as well 
as serotypes for 24 isolates not previously reported. 
c Numbers represent isolates present in Pathogen Tracker on 1 August 2004; detailed source information on isolates can be obtained at www.pathogentracker.net. 
Percentages represent the prevalence of isolates with a given ribotype among all isolates in a given category (e.g., humans). 
d The majority of human isolates (�90%) were from invasive listeriosis cases in North America. 
e Animal isolates included isolates from animals with invasive listeriosis as well as fecal isolates from animals without symptoms of listeriosis, the majority of which 
(�95%) were from North America. 
f The majority of food isolates (�95%) were from North America. *, statistically signiﬁcantly (P � 0.0001) more common among food isolates than among human 
isolates. 
g Other isolates included isolates from various environments, including food processing plants, as well as isolates of unknown origin. 
cases (18). The majority (n � 40) of the ruminant fecal isolates 
characterized in this study belonged to lineage II, which pre­
dominantly includes serotypes 1/2a and 1/2c (23). Thus, the 
lack of inlA premature stop codon mutations among animal 
isolates does not appear to represent an overrepresentation of 
isolates of serotype 4b, which is predominantly found among 
lineage I isolates and not found in lineage II isolates. We also 
recently identiﬁed a frameshift mutation in the 5� portion of 
inlA, leading to a PMSC in the signal sequence of InlA (Fig. 1). 
This frameshift mutation was observed in L. monocytogenes 
isolates from foods that were characterized as ribotype DUP­
1039C and serotype 1/2c (R. Orsi and M. Wiedmann, unpub­
lished data). Interestingly, previous studies in France only 
identiﬁed inlA PMSC mutations 3� of the LRR region of InlA 
in serotype 1/2c and 1/2a isolates (11), further conﬁrming that 
the inlA PMSCs observed here represent genetic events inde­
pendent from those leading to the emergence of the inlA 
PMSCs in France. The fact that at least nine independent 
evolutionary events (Fig. 1) in both of the major L. monocy­
togenes genetic lineages led to the generation of ecologically 
successful inlA alleles carrying PMSC mutations suggests the 
occurrence of positive selection and thus a distinct ecological 
advantage for a loss of cell wall-anchored InlA. 
To further understand the prevalence and distribution of 
PMSC mutation types 1 through 3 among L. monocytogenes 
isolates in the United States, we assembled additional larger 
isolate sets (sets 3 through 6; Table 1) of human clinical iso­
lates and food isolates representing four of the six ribotypes 
found here to carry inlA PMSC mutations (all isolates repre­
senting ribotypes DUP-1031A and DUP-1046B were charac­
terized previously [24]). We screened these isolates using inlA 
sequencing or a newly developed RsaI PCR-RFLP assay tar­
geting the single nucleotide polymorphism (SNP) responsible 
for PMSC mutation type 3, the most common mutation leading 
to truncated and secreted InlA. All isolates representing ribo­
types DUP-16635A, DUP-1031A, DUP-1046B, and DUP­
1062A carried the expected inlA PMSCs (Table 3). In contrast, 
ribotypes DUP-1025A and DUP-1052A contained isolates 
with and without inlA PMSCs (Table 3). While PMSC muta­
tions were more common among food isolates than among 
human clinical isolates belonging to both ribotypes DUP­
1025A and DUP-1052A, this association was only statistically 
signiﬁcant (P � 0.05) for DUP-1052A isolates (Table 3). Ribo­
types DUP-1025A and DUP-1052A contained isolates with 
partial inlA sequences that showed 100% sequence identity 
(within each ribotype), with the exception of their respective 
PMSC mutations, suggesting a recent emergence of these inlA 
allelic types. 
Two recent studies (6, 24) provided initial evidence that L. 
monocytogenes strains known to carry inlA PMSCs rarely cause 
human listeriosis in the United States. We conducted queries 
of the PathogenTracker database (www.pathogentracker.net), 
which contains information for �5,000 L. monocytogenes 
strains isolated predominantly in the United States and North 
America from various sources (e.g., human and animal clinical 
listeriosis cases, foods, healthy animals, and different environ­
ments), to probe the distribution of the ribotypes carrying inlA 
PMSCs on a larger scale. All L. monocytogenes ribotypes found 
here to carry inlA PMSCs were extremely rarely or never detected 
among animal isolates (Table 4), suggesting that a full-length InlA 
protein may play a critical role in animal listeriosis. L. monocyto­
genes ribotypes (DUP-1062A, DUP-16635A, DUP-1031A, and 
DUP-1046B) exclusively associated with PMSC mutations and 
one ribotype that was not exclusively associated with a PMSC 
(DUP-1052A) were more commonly isolated from foods than 
from human clinical cases (Table 4). A �2 test of independence 
showed that ribotype DUP-1062A was signiﬁcantly more com­
mon (P � 0.0001) among food isolates (n � 1,562) than among 
human clinical isolates (n � 1,009). While a total of 52 human 
clinical isolates grouped into one of the ribotypes found to be 
associated with PMSCs, only 19 of these isolates actually car­
ried the inlA PMSC mutations associated with the respective 
ribotypes, as determined by sequencing of the 3� end of inlA. 
Most of the human isolates carrying inlA PMSCs were ob­
tained from blood (n � 16), while a single isolate each was 
obtained from pleural ﬂuid and a skin graft site; no isolation 
site data were available for one isolate. This distribution of 
human isolates with inlA PMSC mutations is consistent with 
results from a recent study in France, which showed that none 
of 61 L. monocytogenes isolates from abortion cases carried a 
truncated InlA protein (11). While these data suggest that InlA 
may be critical for the ability of L. monocytogenes to cause 
abortions, consistent with a study that found a role for inlA in 
the invasion of trophoblasts (16), a recent study using a guinea 
pig model did not support an important role for InlA in cross­
ing the placenta in vivo (1). We thus conclude that L. mono­
cytogenes isolates with PMSCs in inlA represent a considerable 
subpopulation of L. monocytogenes isolates found in food 
which rarely cause human disease and may have a reduced 
ability to cause fetal infections. Further studies using L. mono­
cytogenes isolates with inlA PMSCs will be necessary to evalu­
ate the potential of these strains to cause abortions. 
L. monocytogenes isolates with PMSCs show reduced inva­
sion efﬁciencies. InlA has been shown to be sufﬁcient for the 
invasion of human intestinal epithelial cells by L. monocyto­
genes (21), and previous studies of L. monocytogenes isolates 
from France carrying inlA PMSCs showed that these isolates 
displayed reduced invasion with the Caco-2 human intestinal 
epithelial cell line (27, 28). We paired L. monocytogenes iso­
lates representing each unique inlA PMSC mutation identiﬁed 
here with isolates with homologous partial inlA sequences (ex­
cept for each nonsense mutation) to assess the ability of these 
strains to invade Caco-2 cells (Table 2). While all DUP-1062A 
isolates were shown to harbor an inlA PMSC mutation, partial 
inlA sequences for DUP-1062A isolates were homologous to 
the partial L. monocytogenes EGD-e inlA sequence (5), with 
the exception of PMSC mutation type 3. We thus included 
EGD-e, which groups into lineage II, as do all DUP-1062A iso­
lates, as an initial nonisogenic control for ribotype DUP-1062A. 
L. monocytogenes strains harboring inlA PMSCs showed signiﬁ­
cantly (P � 0.0004) reduced invasion efﬁciencies in Caco-2 cells 
compared to strains with full-length InlA (Fig. 4). Isogenic �inlA 
and �inlAB null mutants showed an invasion capacity similar 
to that of L. monocytogenes strains carrying inlA PMSCs, sup­
porting the critical role of a cell wall-anchored InlA protein for 
the invasion of human intestinal epithelial cells. The invasion 
efﬁciency of the �inlB null mutant was lower than that of the 
isogenic wild-type strain (10403S), but higher than that of the 
corresponding isogenic �inlA mutant, consistent with previous 
reports (14, 15). 
To further characterize the effect of inlA PMSCs on inva­
siveness without confounding other strain differences, we con­
structed an isogenic L. monocytogenes 10403S mutant (FSL 
W3-084; Table 2) with inlA PMSC mutation type 3. This iso­
genic mutant was shown to produce a truncated and secreted 
InlA protein (Fig. 2) and also showed reduced Caco-2 cell 
invasion efﬁciency, similar to natural L. monocytogenes isolates 
carrying PMSC types 1, 2, and 3. These data further support 
the observation that L. monocytogenes strains with inlA PMSCs 
are characterized by attenuated invasiveness and thus indicate 
that SNPs in inlA may be suitable targets for the development 
of rapid assays for the detection of virulence-attenuated 
L. monocytogenes. However, based on the data presented here, 
it is not possible to differentiate whether these inlA PMSC 
FIG. 4. Caco-2 cell invasion efﬁciency of L. monocytogenes isolates 
with inlA PMSC mutations. The isolates tested included L. monocyto­
genes 10403S and an isogenic mutant with inlA PMSC mutation type 3 
(FSL W3-084) as well as three pairs of wild-type strains with homol­
ogous 3� inlA sequences, with and without the respective PMSC mu­
tation types 1, 2, and 3; in addition, four control strains (10403S 
isogenic �inlA, �inlB, and �inlA null mutants) were included (Table 
2). The invasion efﬁciency of each L. monocytogenes strain was assayed 
in triplicate in each independent experiment, and three independent 
invasion experiments were performed for each strain. Bars represent 
median invasion efﬁciencies (% of intracellular bacteria relative to 
initial inoculum), and error bars indicate the minimum and maximum 
invasion efﬁciencies observed for each strain or isolate. A nonpara­
metric approximation of a t test showed that L. monocytogenes isolates 
with inlA PMSC mutations have signiﬁcantly (P � 0.0004) reduced 
invasion efﬁciencies in Caco-2 cells compared to isolates with an inlA 
gene encoding full-length InlA. 
mutations are fully responsible for the attenuated virulence 
phenotype or whether these inlA PMSCs accumulated as a 
result of the evolution of environmentally adapted ecotypes 
with already reduced virulence, which did not require a full-
length InlA protein for ecological success. Further studies us­
ing a carefully planned set of isogenic mutants (including a 
DUP-1062A isolate with a replacement of PMSC mutation 
type 3) and appropriate animal infection models (17) are nec­
essary to more conclusively deﬁne the contribution of the inlA 
PMSC mutations observed here to virulence attenuation, par­
ticularly in light of recent data that showed that isogenic res­
toration of another inlA PMSC failed to completely restore 
virulence in a chicken embryo assay (27). 
Truncated and secreted InlA is not associated with a healthy 
L. monocytogenes fecal carriage state in ruminants. The occur­
rence of at least nine distinct evolutionary events that gave rise 
to ecologically successful inlA allelic variants carrying PMSC 
mutations supports the hypothesis that the production of a 
truncated and secreted InlA protein may provide a distinct 
selective advantage in at least some speciﬁc niche. Olier et al. 
(28) suggested that L. monocytogenes strains with truncated 
InlA may be associated with a human fecal carriage state. 
However, recent studies indicated that the prevalence of L. 
monocytogenes in human stool samples from the general pop­
ulation is often �1% (8, 9, 33). Since fecal L. monocytogenes 
carriage in healthy farm ruminants appears to be quite com­
mon (20, 25, 40), we hypothesized that a truncated and se­
creted InlA may be associated with L. monocytogenes fecal 
carriage in healthy ruminants. Screening by sequencing ap­
proximately 1,600 bp at the 3� end of inlA of 58 L. monocyto­
genes fecal isolates from healthy ruminants (set 2; Table 1), 
representing ribotypes commonly isolated from ruminant fecal 
samples, showed that none of these 58 isolates carried PMSCs 
in the 3� 1,600 bp of inlA. These results are consistent with 
Pathogen Tracker database query results, which showed a very 
low prevalence of ribotypes associated with inlA PMSCs 
among 1,297 animal isolates (Table 4). We thus conclude that 
ruminants, including animals with clinical listeriosis and 
asymptomatic fecal carriers, do not represent a reservoir for L. 
monocytogenes strains with inlA PMSCs. 
Conclusions. While several lines of evidence suggest that 
L. monocytogenes strains differ in their ability to cause human 
disease (6, 11), limited information on the speciﬁc genetic 
characteristics responsible for these virulence differences is 
available. In conjunction with a recent study of 150 food and 
300 human isolates collected in France (11), our data strongly 
suggest that a considerable proportion of L. monocytogenes 
strains isolated from foods have a reduced ability to invade 
human intestinal epithelial cells. Our data also support that 
this attenuated invasiveness is linked to multiple distinct SNPs 
in inlA which lead to the production of truncated and secreted 
InlA molecules. Since L. monocytogenes strains with inlA 
PMSCs have been isolated from some human cases, further 
studies to determine whether human listeriosis cases caused by 
isolates with PMSCs in inlA are associated with speciﬁc host 
factors (e.g., extreme immunosuppression) are appropriate. 
Nevertheless, the data presented here have important impli­
cations for microbial risk assessments and regulations targeting 
L. monocytogenes by identifying genetically well-deﬁned and 
biologically meaningful L. monocytogenes subpopulations that 
appear to have reduced human virulence. In addition to the 
signiﬁcance of our ﬁndings for food safety and public health, 
our data contribute to our understanding of the ecology and 
evolution of L. monocytogenes. In particular, future efforts to 
elucidate the selective advantages associated with the produc­
tion of a truncated and secreted InlA protein may provide a 
better understanding of the function of L. monocytogenes in­
ternalins in different hosts and nonhost environments. 
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